| Stage | RYZ | % of rev | ASH | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.2B | 100.00% | $497M | 100.00% | RYZ ×4.38 |
| Gross profit | $374M | 17.16% | $170M | 34.21% | ASH +17.0pp |
| Operating income | $52M | 2.36% | $43M | 8.65% | ASH +6.3pp |
| Pre-tax income | $36M | 1.67% | $56M | 11.27% | ASH +9.6pp |
| Net income | $33M | 1.49% | $16M | 3.22% | ASH +1.7pp |
| Stage | RYZ | ASH | Gap · A − B |
|---|---|---|---|
| Revenue | $2.2B100.00% | $497M100.00% | RYZ ×4.38 |
| Gross profit | 17.16%$374M | 34.21%$170M | ASH +17.0pp |
| Operating income | 2.36%$52M | 8.65%$43M | ASH +6.3pp |
| Pre-tax income | 1.67%$36M | 11.27%$56M | ASH +9.6pp |
| Net income |
| 1.49%$33M |
| 3.22%$16M |
| ASH +1.7pp |
None
No disclosed counterparties: RYZ.